On the development of the medical research council trial of α‐interferon in metastatic renal carcinoma
Peter Fayers(University of Aberdeen), PM Yuen(Regional Health), Nora Donaldson(University of Reading), R.T.D. Oliver(University of Cambridge), John Whitehead(Lancaster City Council), David Machin(National Medical Research Council), A. Ritchie(Regional Health), Pat Cook(European Organisation for Research and Treatment of Cancer)
Cited by 20
Related Papers
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Sample Size Tables for Clinical Studies
|Unknown|2008|1.3k
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
|Quality of Life Research|2013|855
A general parametric approach to the meta‐analysis of randomized clinical trials
|Statistics in Medicine|1991|765